Welcome to the ViiV UK Nurse Network. You asked, we listened. Here we have included useful resources for Vocabria(cabotegravir) and Rekambys(rilpivirine) long-acting injectables for nurses written by nurses.

Nurse in hospital

Nurses are key in developing and managing the delivery of Vocabria and Rekambys for people living with HIV. They know people well, spending more time with them and therefore gaining a deep meaningful understanding of their medical & psychosocial needs.

UK nurses have developed useful resources, which include:

  • Top tips of implementing Vocabria and Rekambys: bringing to life how UK nurses run their HIV injectable service considering what has worked well as where there is room for improvement.
  • Case studies which show people's experience on Vocabria and Rekambys and also demonstrate the nurses’ role in patient identification.

Hopefully these resources resonate with you as they show what is happening with real people in the UK. They are also representative of different areas of the UK, in both small and large clinic-settings, and also within the community. We hope you enjoy reading the content and that they support you with implementation of your own injectable HIV service.

Meet the UK ViiV Nurse Specialist Advisor Team

ViiV UK HIV Nurse Advisor - Liz Foote

Liz Foote

“I have worked in HIV since 1993 where I was a HIV buddy for a voluntary organisation. I have worked as a specialist nurse in HIV, blood borne viruses and palliative care since 1996. The field of HIV has taken me on an amazing journey and I have worked all over the UK and for three years in Cambodia. I am a nurse prescriber, I have my masters level 7 in physical examination and have a masters in Drug use and addiction. I was on the executive committee of National HIV Nurses Association for 8 years and chair for 2 years. I am passionate about high quality HIV care being delivered to every single person. I joined ViiV in September 2023 as a HIV Nurse Specialist Advisor.”

ViiV UK HIV Nurse Advisor - Shaun Watson

Shaun Watson

“I have worked in HIV since 1991 initially in hospice care and management. I then worked as an adherence nurse specialist and as a community nurse for the past 20 years in London. I was on the executive committee of the National HIV Nurses Association for 10 years and chair for 4 years. I joined ViiV in August 2021 as a HIV Nurse Specialist Advisor.”

Send us your feedback and suggestions,

Email us any feedback or suggestions on what you would like to see from the Nurse Network in future. Once you have submitted this, we at ViiV Healthcare UK will review and take onboard for future!


  1. VOCABRIA Summary of Product Characteristics. ViiV Healthcare.
  2. REKAMBYS Summary of Product Characteristics. Janssen.

REKAMBYS (rilpivirine long-acting injection), including the trademark is owned by the Janssen Pharmaceutical Companies and used under license by the ViiV Healthcare group of companies. All other trademarks are owned by the ViiV 
Healthcare group

PM-GB-CBR-WCNT-230011 | February 2024

Adverse event reporting

Adverse events should be reported. Reporting forms and information can be found at or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221441.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.